Comparison of aqueous humour and vitreous humour levels of two 0.3% ciprofloxacin eyedrops

Canadian Journal of Ophthalmology

Volumn 33, Issue 7, 1998, Pages 373-376

  Çekiç, Osman ^a,c   Batman, Cosar ^a   Yasar, Ümit ^b   Basci, Nursabah E ^b   Bozkurt, Atilla ^b   Kayaalp, S Oguz ^b  

^a SSK Ankara Eye Hospital   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c Basak Sokak No 54/7   (Turkey)

Author keywords

Aqueous humour; Ciprofloxacin; Eyedrop; High performance liquid chromatography; Vitreous humour

Indexed keywords

CIPROFLOXACIN; SIPROGUT; UNCLASSIFIED DRUG;

ADULT; AQUEOUS HUMOR; ARTICLE; CLINICAL ARTICLE; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG PENETRATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; VITREOUS BODY;

EID: 0032300092     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Donnenfeld ED, Schrier A, Perry HD, Aulicino T, Gombert ME, Snyder R. Penetration of topically applied ciprofloxacin, norfloxacin, and ofloxacin into aqueous humor. Ophthalmology 1994;101:902-5.
2. Wolfson JS, Hooper DC. The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitro. Antimicrob Agents Chemother 1985;28:581-6.
3. Keren G, Alhalel A, Bartov E, Cohen RK, Rubinstein E, Segev S, et al. The intravitreal penetration of orally administered ciprofloxacin in humans. Invest Ophthalmol Vis Sci 1991;32:2388-92.
4. Limberg M, Buggé C. Tear concentrations of topically applied ciprofloxacin. Cornea 1994;13:496-9.
5. Hoffken G, Lode H, Prinzing C, Borner K, Koeppe P. Pharmacokinetics of ciprofloxacin after oral and parenteral administration. Antimicrob Agents Chemother 1985;27: 375-9.
6. Madu AA, Mayers M, Perkins R, Liu W, Drusano GL, Aswani R, et al. Aqueous and vitreous penetration of ciprofloxacin following different modes of systemic administration. Exp Eye Res 1996;63:129-36.
7. Basci NE, Bozkurt A, Kalayci D, Kayaalp SO. Rapid liquid chromatographic assay of ciprofloxacin in human aqueous humor. J Pharm Biomed Anal 1996;14:353-6.
8. Lesk MR, Ammann H, Marcil G, Vinet B, Lamer L, Sebag M. The penetration of oral ciprofloxacin into the aqueous humor, vitreous, and subretinal fluids of humans. Am J Ophthalmol 1993;115:623-8.
9. Guzek JP, Chacko D, Kettering JD, Wessels IF, Aprecio RM. Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of experimental Pseudomonas aeruginosa keratitis. Cornea 1994;13:500-4.
10. El Baba FZ, Trousdale MD, Gauderman WJ, Wagner DG, Liggett PE. Intravitreal penetration of oral ciprofloxacin in humans. Ophthalmology 1992;99:483-6.
11. LeBel M. Ciprofloxacin: chemistry, mechanism of action, resistance, antimicrobial spectrum, pharmacokinetics, clinical trials, and adverse reactions. Pharmacotherapy 1998;8:3-33.
12. Kayser FH, Novak J. In vitro activity of ciprofloxacin against gram-positive bacteria. An overview. Am J Med 1987;82:33-9.
13. Kervick GN, Flynn HW Jr, Alfonso E, Miller D. Antibiotic therapy for Bacillus species infections. Am J Ophthalmol 1990;110:683-7.